Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles Pharma's Almanac, 31 Jan 2023 Chimeric antigen receptor (CAR)-T cell therapies have been shown to be effective for the treatment of hematological tumors, but…